Company: MYGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000899923-25-000019
Chunk: 137

Company: MYRIAD GENETICS INC
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 137
---
 of the significant assumptions and inputs used in calculating the estimated amounts to be collected for tests performed. We also tested controls used by management to evaluate the current and historical data used in making the estimates for completeness and accuracy.Our audit procedures over the Company’s revenue included, among others, assessing the methodologies used to estimate consideration expected to be received for tests performed and testing the significant assumptions and the underlying data used by the Company in its analysis. We compared the   significant assumptions used by management to third-party payor collection   trends and other relevant factors. We assessed the reasonableness of   adjustments to estimates of future cash collections as a result of changes in historical and current collection trends and changes in payor behavior. Additionally, we tested management’s supporting calculations. We also performed an evaluation of actual cash collections versus expectations to assess the accuracy of estimates made in prior periods.

/s/ Ernst & Young LLP

We have served as the Company’s auditor since 2006.

Salt Lake City, Utah

February 28, 2025

76

Table of Contents

MYRIAD GENETICS, INC.

AND SUBSIDIARIES

Consolidated Balance Sheets

(in millions, except per share amounts)

December 31,20242023ASSETSCurrent assets:Cash and cash equivalents$102.4 $132.1 Marketable investment securities— 8.8 Trade accounts receivable121.2 114.3 Inventory27.5 22.0 Prepaid taxes16.4 17.0 Prepaid expenses and other current assets30.5 19.4 Total current assets298.0 313.6 Operating lease right-of-use assets55.0 61.6 Property, plant and equipment, net117.4 119.0 Intangibles, net262.4 349.5 Goodwill286.3 287.4 Other assets8.5 15.4 Total assets$1,027.6 $1,146.5 LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable$32.3 $25.8 Accrued liabilities119.0 113.9 Current maturities of operating lease liabilities12.8 16.2 Total current liabilities164.1 155.9 Unrecognized tax benefits32.7 30.2 Long-term debt39.6 38.5 Noncurrent operating lease liabilities87.9